This telemedicine clinic is focused on hormone health and longevity

Hone Health is a New York-based telemedicine clinic known for its cutting-edge approach to preventative and proactive longevity care, and has just recently landed a $33 million Series A investment. With this funding, the company is scaling up and bringing healthcare directly into people's homes through its acquisition of in-home wellness startup ivee.
In an era where traditional primary care is struggling to keep pace with patient needs, Hone Health aims to rewrite the playbook on aging and longevity.
How does it work?
Hone Health started with a simple yet powerful mission: making hormone optimization and longevity care accessible to more people. The company offers a comprehensive approach to health through telemedicine, at-home and in-person lab testing, and expert-led treatment plans.
Patients can monitor over 40 biomarkers and receive personalized protocols, including medications, supplements, dietary adjustments, exercise regimens, stress management, and sleep optimization — all for a starting price of $129 per month.
Now, with the acquisition of ivee, Hone Health is taking things up a notch. Patients can receive treatments from healthcare professionals in the comfort of their homes, expanding access to high-quality, individualized care.
Why does it matter?
Hone Health is tackling a fundamental flaw in healthcare: the reactive nature of traditional medicine. Instead of waiting for chronic diseases like diabetes, heart disease, and cancer to take hold, Hone's approach is proactive.
"Securing this investment is a pivotal moment for Hone Health. It allows us to capitalize on the shift from the broken primary care model to one that helps people live longer while staying healthy as they age," said Saad Alam, Co-founder and CEO of Hone Health.
The company's proprietary patient engine and electronic medical records system house one of the most comprehensive hormone data sets in the world. This data-driven approach enables Hone to expand its expertise beyond men's health into areas like menopause, thyroid issues, and overall longevity care.
The context
We're entering a new era where longevity isn't just a buzzword — it's a movement. More people prioritize healthspan over lifespan, meaning they want to live longer and better. Figures like Dr. Peter Attia have popularized the concept of fighting the "four horsemen" of chronic disease — cancer, cardiovascular disease, diabetes, and dementia — before they take hold.
Venture capitalists are taking note. Hone Health's latest funding round saw backing from major players, including Tribe Capital, Republic Capital, and Vibe VC. Ted Maidenberg from Tribe Ventures underscored the significance of Hone's approach: "Hone Health has quickly emerged as a leader in men's health, prioritizing patient safety and delivering a unique, comprehensive solution that addresses critical market needs."
It's clear that Hone Health isn't just riding the longevity wave — it's shaping the future of how we think about and approach aging. With this latest injection of capital, the company is poised to break new ground, ensuring that the next generation doesn't just live longer but thrives in the process. And it also provides a template for savvy entrepreneurs from the MENA region who could use it and launch something similar in their home market(s). Care to try?
💡Did you know?
You can take your DHArab experience to the next level with our Premium Membership.👉 Click here to learn more
🛠️Featured tool
monday
Built for a new way of working, monday is a stunning project management tool that enables the whole team to collaborate, share updates, see the performance, comments, and more.
👉 Click here to learn more
